News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
STAHL NEIL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/23/2023 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 38,335 shares
@ $833.39, valued at
$31.9M
Sold 6,309 shares
@ $840.53, valued at
$5.3M
Sold 4,574 shares
@ $841.41, valued at
$3.8M
Sold 782 shares
@ $842.16, valued at
$658.6k
Exercised 50,000 options to buy
@ $399.66, valued at
$20M
|
|
| 12/20/2022 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 1,101 shares
@ $0
Granted 4,063 options to buy
@ $726.53, valued at
$3M
|
|
| 12/13/2022 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 330 shares
@ $0
Paid exercise price by delivering 466 shares
@ $753.28, valued at
$351k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2020 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 750 shares
@ $0
Granted 1,688 shares
@ $0
Granted 17,500 options to buy
@ $492, valued at
$8.6M
|
|
| 05/11/2020 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 7,195 shares
@ $560.67, valued at
$4M
Sold 312 shares
@ $567.5, valued at
$177.1k
Sold 792 shares
@ $568.71, valued at
$450.4k
Sold 2,175 shares
@ $569.39, valued at
$1.2M
Sold 2,026 shares
@ $570.28, valued at
$1.2M
Exercised 12,500 options to buy
@ $52.03, valued at
$650.4k
|
|
| 04/15/2020 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 7,582 shares
@ $511.56, valued at
$3.9M
Sold 2 shares
@ $517.99, valued at
$1k
Sold 267 shares
@ $518.54, valued at
$138.5k
Sold 422 shares
@ $519.85, valued at
$219.4k
Sold 2,096 shares
@ $520.43, valued at
$1.1M
Sold 1,595 shares
@ $521.32, valued at
$831.5k
Sold 758 shares
@ $522.37, valued at
$396k
Sold 357 shares
@ $524.26, valued at
$187.2k
Exercised 13,079 options to buy
@ $52.03, valued at
$680.5k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2019 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 2,625 shares
@ $0
Granted 24,500 options to buy
@ $372.46, valued at
$9.1M
|
|
| 11/26/2019 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 5,994 shares
@ $362.75, valued at
$2.2M
Sold 1,422 shares
@ $363.58, valued at
$517k
Sold 2,284 shares
@ $364.2, valued at
$831.8k
Sold 300 shares
@ $365.41, valued at
$109.6k
Exercised 10,000 options to buy
@ $52.03, valued at
$520.3k
|
|
| 11/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2019 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 15,147 shares
@ $304.2, valued at
$4.6M
Sold 6,575 shares
@ $305.43, valued at
$2M
Sold 3,278 shares
@ $306.37, valued at
$1M
Exercised 25,000 options to buy
@ $52.03, valued at
$1.3M
|
|
| 12/14/2018 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 20,000 options to buy
@ $381.4, valued at
$7.6M
|
|
| 05/25/2018 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 15,329 shares
@ $293.68, valued at
$4.5M
Sold 11,407 shares
@ $295.09, valued at
$3.4M
Exercised 26,736 options to buy
@ $30.63, valued at
$818.9k
|
|
| 12/13/2017 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Granted 50,000 options to buy
@ $378.98, valued at
$18.9M
|
|
| 06/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/20/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/18/2015 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Exercised 1,921 options to buy
@ $52.03, valued at
$99.9k
Granted 68,638 options to buy
@ $555.67, valued at
$38.1M
|
|
| 11/09/2015 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Gifted 1,000 shares
@ $0
Paid exercise price by delivering 4,047 shares
@ $567.63, valued at
$2.3M
Paid exercise price by delivering 39,605 shares
@ $567.63, valued at
$22.5M
Paid exercise price by delivering 935 shares
@ $567.63, valued at
$530.7k
Paid exercise price by delivering 13,312 shares
@ $567.63, valued at
$7.6M
Sold 9,555 shares
@ $562.37, valued at
$5.4M
Sold 8,345 shares
@ $563.43, valued at
$4.7M
Sold 2,100 shares
@ $564.19, valued at
$1.2M
Sold 9,694 shares
@ $558.37, valued at
$5.4M
Sold 1,500 shares
@ $559.26, valued at
$838.9k
Sold 3,900 shares
@ $560.31, valued at
$2.2M
|
|
| 12/18/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/24/2014 |
4
| STAHL NEIL (SVP Research and Development S) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 3,107 shares
@ $415.16, valued at
$1.3M
Sold 1,787 shares
@ $409.71, valued at
$732.2k
Sold 413 shares
@ $410.1, valued at
$169.4k
|
|
| 11/20/2014 |
4
| STAHL NEIL (SVP Research and Development S) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 4,747 shares
@ $406.93, valued at
$1.9M
Paid exercise price by delivering 6,703 shares
@ $406.93, valued at
$2.7M
Gifted 250 shares
@ $0
Exercised 16,757 options to buy
@ $115.29, valued at
$1.9M
|
|
| 08/11/2014 |
4
| STAHL NEIL (SVP Research and Development S) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Sold 1,617 shares
@ $339.33, valued at
$548.7k
Sold 9,829 shares
@ $340.04, valued at
$3.3M
Sold 200 shares
@ $341.27, valued at
$68.3k
|
|
| 08/08/2014 |
4
| STAHL NEIL (SVP Research and Development S) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,212 shares
@ $336.11, valued at
$743.5k
Paid exercise price by delivering 18,301 shares
@ $336.11, valued at
$6.2M
Sold 624 shares
@ $340.39, valued at
$212.4k
Sold 117 shares
@ $341.03, valued at
$39.9k
Sold 1,900 shares
@ $340.6, valued at
$647.1k
Sold 200 shares
@ $341, valued at
$68.2k
Exercised 35,000 options to buy
@ $21.25, valued at
$743.8k
|
|
| 02/13/2014 |
4
| STAHL NEIL (SVP Research and Development S) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 2,619 shares
@ $324.44, valued at
$849.7k
Paid exercise price by delivering 20,865 shares
@ $324.44, valued at
$6.8M
Paid exercise price by delivering 414 shares
@ $324.44, valued at
$134.3k
Paid exercise price by delivering 4,234 shares
@ $324.44, valued at
$1.4M
Paid exercise price by delivering 339 shares
@ $324.44, valued at
$110k
Paid exercise price by delivering 3,465 shares
@ $324.44, valued at
$1.1M
Sold 1,800 shares
@ $316.55, valued at
$569.8k
Sold 5,360 shares
@ $317.58, valued at
$1.7M
Sold 6,418 shares
@ $318.51, valued at
$2M
Sold 3,819 shares
@ $319.47, valued at
$1.2M
Sold 3,575 shares
@ $320.6, valued at
$1.1M
|
|
| 12/19/2013 |
4
| STAHL NEIL (SVP Research and Development S) has filed a Form 4 on REGENERON PHARMACEUTICALS INC|
Txns:
| Exercised 4,705 options to buy
@ $21.25, valued at
$100k
|
|
|
|
|